Arbutus Biopharma (ABUS) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $952000.0.
- Arbutus Biopharma's Interest & Investment Income fell 4550.66% to $952000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 2931.98%. This contributed to the annual value of $6.6 million for FY2024, which is 1577.0% up from last year.
- As of Q3 2025, Arbutus Biopharma's Interest & Investment Income stood at $952000.0, which was down 4550.66% from $1.0 million recorded in Q2 2025.
- Arbutus Biopharma's Interest & Investment Income's 5-year high stood at $1.8 million during Q2 2024, with a 5-year trough of $27000.0 in Q3 2021.
- In the last 5 years, Arbutus Biopharma's Interest & Investment Income had a median value of $1.0 million in 2025 and averaged $935947.4.
- Per our database at Business Quant, Arbutus Biopharma's Interest & Investment Income crashed by 8869.57% in 2021 and then surged by 304333.33% in 2022.
- Over the past 5 years, Arbutus Biopharma's Interest & Investment Income (Quarter) stood at $30000.0 in 2021, then surged by 3043.33% to $943000.0 in 2022, then soared by 55.36% to $1.5 million in 2023, then dropped by 0.07% to $1.5 million in 2024, then tumbled by 34.97% to $952000.0 in 2025.
- Its Interest & Investment Income stands at $952000.0 for Q3 2025, versus $1.0 million for Q2 2025 and $1.2 million for Q1 2025.